1. Factor XI as a target for new anticoagulants;Fredenburgh;Hamostasiologie,2021
2. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis;Deitelzweig;Curr. Med. Res. Opin.,2017
3. Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale;Ten Cate;Nat. Rev. Cardiol.,2023
4. Leveraging human genetics to estimate clinical risk reductions achievable by inhibiting factor XI;Georg;Stroke,2019
5. News at XI: moving beyond factor Xa inhibitors;Fredenburg;J. Thromb. Haemost.,2023